Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans

Human Molecular Genetics

Volumn 19, Issue 10, 2010, Pages 1998-2004

  Lesage, Suzanne ^a,b   Patin, Etienne ^c   Condroyer, Christel ^a,b   Leutenegger, Anne Louise ^d,e   Lohmann, Ebba ^a,b   Giladi, Nir ^f,g   Bar Shira, Anat ^f   Belarbi, Soraya ^h   Hecham, Nassima ^h   Pollak, Pierre ⁱ   Ouvrard Hernandez, Anne Marie ⁱ   Bardien, Soraya ^j   Carr, Jonathan ^j   Benhassine, Traki ^k   Tomiyama, Hiroyuki ^l   Pirkevi, Caroline ^m   Hamadouche, Tarik ⁿ   Cazeneuve, Cécile ^o   Basak, A Nazli ^m   Hattori, Nobutaka ^l   Dürr, Alexandra ^a,b,o   Tazir, Meriem ^h   Orr Urtreger, Avi ^f,g   Quintana Murci, Lluis ^c   Brice, Alexis ^a,b,o   more..

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d FONDATION JEAN DAUSSET CEPH   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^g TEL AVIV UNIVERSITY   (Israel)

^h CHU Mustapha   (Algeria)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j STELLENBOSCH UNIVERSITY   (South Africa)

^k UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^l JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m BOGAZICI UNIVERSITY   (Turkey)

ⁿ UNIVERSITY OF BOUMERDES   (Algeria)

^o PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

AFRICA; ARAB; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; EUROPE; FAMILY; GENE MUTATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; JAPAN; JEW; MAJOR CLINICAL STUDY; MOLECULAR EVOLUTION; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

AMINO ACID SUBSTITUTION; ETHNIC GROUPS; EVOLUTION, MOLECULAR; HAPLOTYPES; HUMANS; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES;

EID: 77952476225     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq081     Document Type: Article

References (45)

1. de Rijk, M.C., Breteler, M.M., Graveland, G.A., Ott, A., Grobbee, D.E., van der Meche, F.G. and Hofman, A. (1995) Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology, 45, 2143-2146.
2. Paisan-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simon, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A.M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44, 595-600.
3. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44, 601-607.
4. Giasson, B.I. and Van Deerlin, V.M. (2008) Mutations in LRRK2 as a cause of Parkinson's disease. Neurosignals, 16, 99-105.
5. Cookson, M.R., Dauer, W., Dawson, T., Fon, E.A., Guo, M. and Shen, J. (2007) The roles of kinases in familial Parkinson's disease. J. Neurosci., 27, 11865-11868.
6. Lesage, S., Condroyer, C., Lannuzel, A., Lohmann, E., Troiano, A., Tison, F., Damier, P., Thobois, S., Ouvrard-Hernandez, A.M., Rivaud-Pechoux, S. et al. (2009) Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J. Med. Genet., 46, 458-464.
7. Di Fonzo, A., Rohe, C.F., Ferreira, J., Chien, H.F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N. et al. (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet, 365, 412-415.
8. Gilks, W.P., Abou-Sleiman, P.M., Gandhi, S., Jain, S., Singleton, A., Lees, A.J., Shaw, K., Bhatia, K.P., Bonifati, V., Quinn, N.P. et al. (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet, 365, 415-416.
9. Nichols, W.C., Pankratz, N., Hernandez, D., Paisan-Ruiz, C., Jain, S., Halter, C.A., Michaels, V.E., Reed, T., Rudolph, A., Shults, C.W. et al. (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet, 365, 410-412.
10. Mata, I.F., Wedemeyer, W.J., Farrer, M.J., Taylor, J.P. and Gallo, K.A. (2006) LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci., 29, 286-293.
11. Goldwurm, S., Di Fonzo, A., Simons, E.J., Rohe, C.F., Zini, M., Canesi, M., Tesei, S., Zecchinelli, A., Antonini, A., Mariani, C. et al. (2005) The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J. Med. Genet., 42, e65.
12. Kachergus, J., Mata, I.F., Hulihan, M., Taylor, J.P., Lincoln, S., Aasly, J., Gibson, J.M., Ross, O.A., Lynch, T., Wiley, J. et al. (2005) Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am. J. Hum. Genet., 76, 672-680.
13. Lesage, S., Leutenegger, A.L., Ibanez, P., Janin, S., Lohmann, E., Durr, A. and Brice, A. (2005) LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am. J. Hum. Genet., 77, 330-332.
14. Lesage, S., Durr, A., Tazir, M., Lohmann, E., Leutenegger, A.L., Janin, S., Pollak, P. and Brice, A. (2006) LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med., 354, 422-423.
15. Zabetian, C.P., Hutter, C.M., Yearout, D., Lopez, A.N., Factor, S.A., Griffith, A., Leis, B.C., Bird, T.D., Nutt, J.G., Higgins, D.S. et al. (2006) LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am. J. Hum. Genet., 79, 752-758.
16. Warren, L., Gibson, R., Ishihara, L., Elango, R., Xue, Z., Akkari, A., Ragone, L., Pahwa, R., Jankovic, J., Nance, M. et al. (2008) A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Parkinsonism Relat. Disord., 14, 77-80.
17. Tomiyama, H., Li, Y., Funayama, M., Hasegawa, K., Yoshino, H., Kubo, S., Sato, K., Hattori, T., Lu, C.S., Inzelberg, R. et al. (2006) Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. Mov. Disord., 21, 1102-1108.
18. Zabetian, C.P., Morino, H., Ujike, H., Yamamoto, M., Oda, M., Maruyama, H., Izumi, Y., Kaji, R., Griffith, A., Leis, B.C. et al. (2006) Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Neurology, 67, 697-699.
19. Slatkin, M. and Rannala, B. (2000) Estimating allele age. Annu. Rev. Genomics Hum. Genet., 1, 225-249.
20. Healy, D.G., Falchi, M., O'Sullivan, S.S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C.P., Goldwurm, S. et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol., 7, 583-590.
21. Lu, C.S., Simons, E.J., Wu-Chou, Y.H., Fonzo, A.D., Chang, H.C., Chen, R.S., Weng, Y.H., Rohe, C.F., Breedveld, G.J., Hattori, N. et al. (2005) The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. Parkinsonism Relat. Disord., 11, 521-522.
22. Tan, E.K., Shen, H., Tan, L.C., Farrer, M., Yew, K., Chua, E., Jamora, R.D., Puvan, K., Puong, K.Y., Zhao, Y. et al. (2005) The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci. Lett., 384, 327-329.
23. Fung, H.C., Chen, C.M., Hardy, J., Hernandez, D., Singleton, A. and Wu, Y.R. (2006) Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease. Mov. Disord., 21, 880-881.
24. Ozelius, L.J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A.L., Klein, C., Henick, B., Hailpern, S.M. et al. (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med., 354, 424-425.
25. Punia, S., Behari, M., Govindappa, S.T., Swaminath, P.V., Jayaram, S., Goyal, V., Muthane, U.B., Juyal, R.C. and Thelma, B.K. (2006) Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients. Neurosci. Lett., 409, 83-88.
26. Orr-Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Bar-Shira, A. and Giladi, N. (2007) The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology, 69, 1595-1602.
27. Hulihan, M.M., Ishihara-Paul, L., Kachergus, J., Warren, L., Amouri, R., Elango, R., Prinjha, R.K., Upmanyu, R., Kefi, M., Zouari, M. et al. (2008) LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol., 7, 591-594.
28. Lesage, S., Belarbi, S., Troiano, A., Condroyer, C., Hecham, N., Pollak, P., Lohman, E., Benhassine, T., Ysmail-Dahlouk, F., Durr, A. et al. (2008) Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease? Neurology, 71, 1550-1552.
29. Altshuler, D., Daly, M.J. and Lander, E.S. (2008) Genetic mapping in human disease. Science, 322, 881-888.
30. Pirkevi, C., Lesage, S., Condroyer, C., Tomiyama, H., Hattori, N., Ertan, S., Brice, A. and Basak, A.N. (2009) A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype. Neurogenetics, 10, 271-273.
31. Adams, S.M., Bosch, E., Balaresque, P.L., Ballereau, S.J., Lee, A.C., Arroyo, E., Lopez-Parra, A.M., Aler, M., Grifo, M.S., Brion, M. et al. (2008) The genetic legacy of religious diversity and intolerance: paternal lineages of Christians, Jews, and Muslims in the Iberian Peninsula. Am. J. Hum. Genet., 83, 725-736.
32. Bar-Shira, A., Hutter, C.M., Giladi, N., Zabetian, C.P. and Orr-Urtreger, A. (2009) Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries. Neurogenetics, 10, 355-358. Epub 2009 March 13.
33. Behar, D.M., Metspalu, E., Kivisild, T., Achilli, A., Hadid, Y., Tzur, S., Pereira, L., Amorim, A., Quintana-Murci, L., Majamaa, K. et al. (2006) The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event. Am. J. Hum. Genet, 78, 487-497.
34. Behar, D.M., Metspalu, E., Kivisild, T., Rosset, S., Tzur, S., Hadid, Y., Yudkovsky, G., Rosengarten, D., Pereira, L., Amorim, A. et al. (2008) Counting the founders: the matrilineal genetic ancestry of the Jewish Diaspora. PLoS One, 3, e2062.
35. Lesage, S., Ibanez, P., Lohmann, E., Pollak, P., Tison, F., Tazir, M., Leutenegger, A.L., Guimaraes, J., Bonnet, A.M., Agid, Y. et al. (2005) G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann. Neurol., 58, 784-787.
36. Lohmann, E., Leclere, L., De Anna, F., Lesage, S., Dubois, B., Agid, Y., Dürr, A. and Brice, A. and French Parkinson's Disease Genetics Study Group (2009) A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations. Parkinsonism Relat. Disord., 15, 273-276.
37. Lesage, S., Janin, S., Lohmann, E., Leutenegger, A.L., Leclere, L., Viallet, F., Pollak, P., Durif, F., Thobois, S., Layet, V. et al. (2007) LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans. Arch. Neurol., 64, 425-430.
38. Lesage, S., Leclere, L., Lohmann, E., Borg, M., Ruberg, M., Durr, A. and Brice, A. (2007) Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease. Neurodegener. Dis., 4, 195-198.
39. Benson, G. (1999) Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res., 27, 573-580.
40. Stephens, M. and Donnelly, P. (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet., 73, 1162-1169.
41. Bandelt, H.J., Forster, P. and Rohl, A. (1999) Median-joining networks for inferring intraspecific phylogenies. Mol. Biol. Evol., 16, 37-48.
42. Austerlitz, F., Kalaydjieva, L. and Heyer, E. (2003) Detecting population growth, selection and inherited fertility from haplotypic data in humans. Genetics, 165, 1579-1586.
43. Genin, E., Tullio-Pelet, A., Begeot, F., Lyonnet, S. and Abel, L. (2004) Estimating the age of rare disease mutations: the example of Triple-A syndrome. J. Med. Genet., 41, 445-449.
44. Frazer, K.A., Ballinger, D.G., Cox, D.R., Hinds, D.A., Stuve, L.L., Gibbs, R.A., Belmont, J.W., Boudreau, A., Hardenbol, P., Leal, S.M. et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-861.
45. Brinkmann, B., Klintschar, M., Neuhuber, F., Huhne, J. and Rolf, B. (1998) Mutation rate in human microsatellites: influence of the structure and length of the tandem repeat. Am. J. Hum. Genet., 62, 1408-1415.